PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
418
Total Open
Publications
204
Total
Citations
13K
Open Access
Percentage
49%
Total
Publications
418
Total Open
Publications
204
Total
Citations
13K
Breakdown
Publisher Open
16%
Both
25%
Other Platform Open
6%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
60
Hybrid 39%
65
No Guarantees 25%
41
Other Platform Open
Domain 85%
110
Other Internet 25%
32
Institution 15%
19
Public 4%
5
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 111 |
DOI | Other Internet | 20 |
Unknown Repository | Other Internet | 11 |
Figshare | Public | 5 |
University of Melbourne - Minerva Access | Institution | 4 |
JAMA - The Journal of the American Medical Association Network | Institution | 4 |
Europe PMC | Domain | 3 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 2 |
University of Pisa - CINECA IRIS Institutial research information system | Institution | 2 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 2 |